1. Home
  2. TNXP vs CLWT Comparison

TNXP vs CLWT Comparison

Compare TNXP & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • CLWT
  • Stock Information
  • Founded
  • TNXP 2007
  • CLWT 1971
  • Country
  • TNXP United States
  • CLWT Hong Kong
  • Employees
  • TNXP N/A
  • CLWT N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • CLWT Professional and commerical equipment
  • Sector
  • TNXP Health Care
  • CLWT Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • CLWT Nasdaq
  • Market Cap
  • TNXP 272.0M
  • CLWT 8.9M
  • IPO Year
  • TNXP N/A
  • CLWT 1997
  • Fundamental
  • Price
  • TNXP $35.17
  • CLWT $1.15
  • Analyst Decision
  • TNXP Strong Buy
  • CLWT
  • Analyst Count
  • TNXP 2
  • CLWT 0
  • Target Price
  • TNXP $585.00
  • CLWT N/A
  • AVG Volume (30 Days)
  • TNXP 736.3K
  • CLWT 16.2K
  • Earning Date
  • TNXP 08-15-2025
  • CLWT 04-30-2025
  • Dividend Yield
  • TNXP N/A
  • CLWT N/A
  • EPS Growth
  • TNXP N/A
  • CLWT N/A
  • EPS
  • TNXP N/A
  • CLWT 0.10
  • Revenue
  • TNXP $10,041,000.00
  • CLWT $15,383,000.00
  • Revenue This Year
  • TNXP $11.66
  • CLWT N/A
  • Revenue Next Year
  • TNXP $793.18
  • CLWT N/A
  • P/E Ratio
  • TNXP N/A
  • CLWT $11.99
  • Revenue Growth
  • TNXP N/A
  • CLWT N/A
  • 52 Week Low
  • TNXP $6.76
  • CLWT $1.01
  • 52 Week High
  • TNXP $130.00
  • CLWT $1.76
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 52.73
  • CLWT 48.85
  • Support Level
  • TNXP $33.71
  • CLWT $1.07
  • Resistance Level
  • TNXP $36.20
  • CLWT $1.17
  • Average True Range (ATR)
  • TNXP 3.05
  • CLWT 0.05
  • MACD
  • TNXP -0.45
  • CLWT -0.00
  • Stochastic Oscillator
  • TNXP 67.58
  • CLWT 47.12

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

Share on Social Networks: